Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Giri

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
Trends in Cardiovascular Medicine|April 27, 2016
Editorial Commentary: Guidance through the "Toolshed" for endovascular revascularization of the lower extremityJay Giri, Zoltan Arany
JACC. Cardiovascular Interventions|August 31, 2020
Peri-Procedural Stroke With Carotid Artery Stenting: How Low Can You Go?Jay Giri, Mougnyan Cox
Lancet (London, England)|August 24, 2017
Intravenous fibrinolytics in STEMI: a 25-year perspectiveSaurav Chatterjee, Jay Giri
JACC. Cardiovascular Interventions|March 19, 2018
Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?Jay Giri, Ashwin Nathan
Vascular Medicine (London, England)|March 6, 2019
Keep it simple? Half-dose systemic thrombolysis or catheter-directed thrombolysis for pulmonary embolismRim Halaby, Jay Giri
Circulation. Cardiovascular Quality and Outcomes|February 19, 2019
Paradigm Shifts in the Treatment of Stable Ischemic Heart DiseaseSrinath Adusumalli, Jay Giri
Current Medical Research and Opinion|July 31, 2008
Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelinesEmile Mohler, Jay Giri, , et al.
JAMA|October 17, 2014
Benefits and risks associated with thrombolysis for pulmonary embolism--replySaurav Chatterjee, Jay Giri
The American Journal of Cardiology|September 13, 2015
Insight into "public" reporting of percutaneous coronary interventions in the state of PennsylvaniaTaisei Kobayashi, Jay Giri
JACC. Cardiovascular Interventions|November 19, 2021
Coronary Stents: From Revolution, to Evolution, to Pursuit of PerfectionJay Giri, Rim Halaby
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
Trends in Cardiovascular Medicine|April 27, 2016
Editorial Commentary: Guidance through the "Toolshed" for endovascular revascularization of the lower extremityJay Giri, Zoltan Arany
JACC. Cardiovascular Interventions|August 31, 2020
Peri-Procedural Stroke With Carotid Artery Stenting: How Low Can You Go?Jay Giri, Mougnyan Cox
Lancet (London, England)|August 24, 2017
Intravenous fibrinolytics in STEMI: a 25-year perspectiveSaurav Chatterjee, Jay Giri
JACC. Cardiovascular Interventions|March 19, 2018
Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?Jay Giri, Ashwin Nathan
Vascular Medicine (London, England)|March 6, 2019
Keep it simple? Half-dose systemic thrombolysis or catheter-directed thrombolysis for pulmonary embolismRim Halaby, Jay Giri
Circulation. Cardiovascular Quality and Outcomes|February 19, 2019
Paradigm Shifts in the Treatment of Stable Ischemic Heart DiseaseSrinath Adusumalli, Jay Giri
Current Medical Research and Opinion|July 31, 2008
Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelinesEmile Mohler, Jay Giri, , et al.
JAMA|October 17, 2014
Benefits and risks associated with thrombolysis for pulmonary embolism--replySaurav Chatterjee, Jay Giri
The American Journal of Cardiology|September 13, 2015
Insight into "public" reporting of percutaneous coronary interventions in the state of PennsylvaniaTaisei Kobayashi, Jay Giri
JACC. Cardiovascular Interventions|November 19, 2021
Coronary Stents: From Revolution, to Evolution, to Pursuit of PerfectionJay Giri, Rim Halaby
Pageof 26